Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

May 10, 2024

SELL
$0.66 - $1.81 $65,250 - $178,943
-98,864 Reduced 88.83%
12,431 $10,000
Q2 2022

Jun 20, 2023

BUY
$0.66 - $1.81 $8,204 - $22,500
12,431 New
12,431 $10,000
Q2 2022

Mar 22, 2023

SELL
$0.66 - $1.81 $65,250 - $178,943
-98,864 Reduced 88.83%
12,431 $10,000
Q2 2022

Aug 11, 2022

SELL
$0.66 - $1.81 $65,250 - $178,943
-98,864 Reduced 88.83%
12,431 $10,000
Q1 2022

May 10, 2024

BUY
$1.27 - $2.47 $141,344 - $274,898
111,295 New
111,295 $184,000
Q1 2022

Jun 20, 2023

BUY
$1.27 - $2.47 $141,344 - $274,898
111,295 New
111,295 $184,000
Q1 2022

Mar 22, 2023

BUY
$1.27 - $2.47 $51,880 - $100,901
40,851 Added 57.99%
111,295 $184,000
Q1 2022

May 12, 2022

BUY
$1.27 - $2.47 $51,880 - $100,901
40,851 Added 57.99%
111,295 $185,000
Q4 2021

May 17, 2024

BUY
$2.21 - $3.22 $48,363 - $70,466
21,884 Added 45.07%
70,444 $164,000
Q4 2021

Jun 21, 2023

BUY
$2.21 - $3.22 $155,681 - $226,829
70,444 New
70,444 $164,000
Q4 2021

Mar 22, 2023

BUY
$2.21 - $3.22 $48,363 - $70,466
21,884 Added 45.07%
70,444 $164,000
Q4 2021

Feb 15, 2022

BUY
$2.21 - $3.22 $48,363 - $70,466
21,884 Added 45.07%
70,444 $165,000
Q3 2021

May 17, 2024

SELL
$2.8 - $3.72 $71,626 - $95,161
-25,581 Reduced 34.5%
48,560 $151,000
Q3 2021

Jun 21, 2023

BUY
$2.8 - $3.72 $135,968 - $180,643
48,560 New
48,560 $151,000
Q3 2021

Mar 22, 2023

SELL
$2.8 - $3.72 $71,626 - $95,161
-25,581 Reduced 34.5%
48,560 $151,000
Q3 2021

Nov 15, 2021

SELL
$2.8 - $3.72 $71,626 - $95,161
-25,581 Reduced 34.5%
48,560 $151,000
Q2 2021

Jun 21, 2023

BUY
$2.61 - $4.17 $193,508 - $309,167
74,141 New
74,141 $248,000
Q1 2021

May 17, 2024

BUY
$2.91 - $4.32 $215,750 - $320,289
74,141 New
74,141 $230,000
Q1 2021

Jun 26, 2023

BUY
$2.91 - $4.32 $215,750 - $320,289
74,141 New
74,141 $231 Million
Q1 2021

Mar 22, 2023

BUY
$2.91 - $4.32 $82,198 - $122,027
28,247 Added 61.55%
74,141 $230,000
Q1 2021

May 14, 2021

BUY
$2.91 - $4.32 $82,198 - $122,027
28,247 Added 61.55%
74,141 $231,000
Q4 2020

May 24, 2024

SELL
$2.15 - $3.5 $19,850 - $32,315
-9,233 Reduced 16.75%
45,894 $126,000
Q4 2020

Jun 22, 2023

BUY
$2.15 - $3.5 $98,672 - $160,629
45,894 New
45,894 $126,000
Q4 2020

Mar 22, 2023

SELL
$2.15 - $3.5 $19,850 - $32,315
-9,233 Reduced 16.75%
45,894 $126,000
Q4 2020

Feb 16, 2021

SELL
$2.15 - $3.5 $19,850 - $32,315
-9,233 Reduced 16.75%
45,894 $126,000
Q3 2020

May 24, 2024

SELL
$2.77 - $6.17 $64,937 - $144,643
-23,443 Reduced 29.84%
55,127 $158 Million
Q3 2020

Jun 26, 2023

BUY
$2.77 - $6.17 $152,701 - $340,133
55,127 New
55,127 $157,000
Q3 2020

Mar 22, 2023

SELL
$2.77 - $6.17 $64,937 - $144,643
-23,443 Reduced 29.84%
55,127 $157,000
Q3 2020

Nov 13, 2020

SELL
$2.77 - $6.17 $64,937 - $144,643
-23,443 Reduced 29.84%
55,127 $158,000
Q2 2020

May 24, 2024

BUY
$0.87 - $3.13 $68,355 - $245,924
78,570 New
78,570 $244 Million
Q2 2020

Jun 26, 2023

BUY
$0.87 - $3.13 $68,355 - $245,924
78,570 New
78,570 $243,000
Q2 2020

Mar 22, 2023

BUY
$0.87 - $3.13 $68,355 - $245,924
78,570 New
78,570 $243,000
Q2 2020

Aug 14, 2020

BUY
$0.87 - $3.13 $68,355 - $245,924
78,570 New
78,570 $244,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.